What stocks does Nippon India Pharma Fund hold?

Nippon India Pharma Fund holds a portfolio of Indian equity stocks disclosed monthly by Nippon India Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Nippon India Pharma Fund?

Nippon India Pharma Fund is managed by Nippon India Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Nippon India Pharma Fund?

Nippon India Pharma Fund is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is Nippon India Pharma Fund portfolio data updated?

Portfolio holdings for Nippon India Pharma Fund are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Nippon India Mutual Fund

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Equity Data as of Aug 2026 Comparing Jul 2026 → Aug 2026

Share: WhatsApp X

⌕

Stocks Held

Aug 2026

Equity Holdings

₹9,289.14 Cr

Equity only, excl. debt & cash

AAUM

₹8,280.57 Cr

Apr-Jun 2026 · Direct + Regular

Top 5 Weight

37.0%

Moderate

Top 10 Weight

56.8%

Moderate

Changes

1 new · 0 exits

Top Sector

Pharmaceuticals & Biotechnology

74.0% of portfolio

Launch Date

10 May 2004

10+ year track record

AAUM (Average Assets Under Management) of ₹8,280.57 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month Nippon India Pharma Fund added 1 new stock to its portfolio this month. The biggest new buy was Molbio Diagnostics Ltd. (Healthcare Equipment & Supplies) at 0.44% weight. Among existing holdings, GlaxoSmithKline Pharmaceuticals Limited saw the biggest increase — now at 3.31% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 12.37%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 74.0%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

-0.95%

+6.08%

+13.29%

+10.30%

Latest NAV

₹638.36

11 Sep 2026

52W High

₹653.61

-2% from High

52W Low

₹505.76

+26% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+35.3%

2023

+40.4%

2022

-9.1%

2021

+25.1%

2020

+67.9%

2019

+2.5%

2018

+4.6%

2017

+8.6%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

18.4%

+ve in 75% windows

88.4% / -14.9%

3Y Rolling Avg

19.4% p.a.

+ve in 99% windows

33.5% / -1.6%

5Y Rolling Avg

20.1% p.a.

+ve in 100% windows

32.2% / 12.3%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-14.7%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-21.2%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.1%

Rec: Jun 2023 (1yr 5mo)

2018 IL&FS

-11.3%

Rec: Feb 2020 (1yr 11mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. · CAGR, Sharpe Ratio & Standard Deviation — Mutual Fund Guide →

Sharpe Ratio (3Y)

0.93

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

1.37

Penalises downside volatility only.

Std Deviation (3Y)

12.9%

Lower = more consistent returns.

NAV Chart ₹638.36 11 Sep 2026

Simple Moving Avg: Click to draw · click again to remove

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Chart shows indexed performance (base = 100). Actual NAV: ₹638.36

Sector Shift Industry allocation month-over-month

Jun 2026 → Jul 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	72.5%	73.5%	▲ +1.0%
Healthcare Services	22.0%	21.1%	▼ -0.9%
Retailing	3.2%	2.7%	▼ -0.5%

Jul 2026 → Aug 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	73.5%	74.0%	▲ +0.5%
Healthcare Services	21.1%	21.1%	● -0.1%
Retailing	2.7%	2.5%	▼ -0.2%
Healthcare Equipment & Supplies	0.0%	0.4%	▲ +0.4%

🟢

Biggest New Buy

Molbio Diagnostics Ltd.

0.44% weight · Healthcare Equipment & Supplies

↑

Biggest Add

GlaxoSmithKline Pharmaceuticals Limited

+0.65% · now 3.31%

↓

Biggest Trim

Sun Pharmaceutical Industries Limited

-0.94% · now 12.37%

🤝 Other funds also bought this month

Molbio Diagnostics Ltd. 15 funds

What Changed in the Portfolio This Month?

Comparing Jul 2026 → Aug 2026

Jul 2026 → Aug 2026

🟢 1 New Entry ↑ 17 Increased ↓ 17 Decreased

#	Stock	Sector	Weight (Aug 2026)
1	Molbio Diagnostics Ltd. ₹41.31 Cr	Healthcare Equipment & Supplies	0.44%

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	GlaxoSmithKline Pharmaceuticals Limited ₹314.00 Cr	Pharmaceuticals & Biotechnology	2.66%	3.31%	+0.65%
2	Divi's Laboratories Limited ₹663.40 Cr	Pharmaceuticals & Biotechnology	6.52%	7.00%	+0.48%
3	Mankind Pharma Limited ₹387.93 Cr	Pharmaceuticals & Biotechnology	3.74%	4.09%	+0.35%
4	Suraksha Diagnostic Ltd ₹131.91 Cr	Healthcare Services	1.06%	1.39%	+0.33%
5	Sai Life Sciences Limited ₹373.06 Cr	Pharmaceuticals & Biotechnology	3.62%	3.94%	+0.32%
6	Gland Pharma Limited ₹231.02 Cr	Pharmaceuticals & Biotechnology	2.16%	2.44%	+0.28%
7	Anthem Biosciences Limited ₹113.87 Cr	Pharmaceuticals & Biotechnology	0.92%	1.20%	+0.28%
8	IPCA Laboratories Limited ₹269.52 Cr	Pharmaceuticals & Biotechnology	2.57%	2.84%	+0.27%
9	Vijaya Diagnostic Centre Limited ₹253.82 Cr	Healthcare Services	2.42%	2.68%	+0.26%
10	Biocon Limited ₹103.17 Cr	Pharmaceuticals & Biotechnology	0.92%	1.09%	+0.17%
11	Piramal Pharma Limited ₹213.06 Cr	Pharmaceuticals & Biotechnology	2.09%	2.25%	+0.16%
12	Akums Drugs and Pharmaceuticals Limited ₹104.98 Cr	Pharmaceuticals & Biotechnology	1.00%	1.11%	+0.11%
13	Aurobindo Pharma Limited ₹154.98 Cr	Pharmaceuticals & Biotechnology	1.54%	1.63%	+0.09%
14	Cipla Limited ₹577.08 Cr	Pharmaceuticals & Biotechnology	6.03%	6.09%	+0.06%
15	Ajanta Pharma Limited ₹329.18 Cr	Pharmaceuticals & Biotechnology	3.41%	3.47%	+0.06%
16	Indoco Remedies Ltd ₹44.65 Cr	Pharmaceuticals & Biotechnology	0.43%	0.47%	+0.04%
17	Syngene International Limited ₹140.32 Cr	Healthcare Services	1.46%	1.48%	+0.02%

#	Stock	Sector	Jul 2026	Aug 2026	Change
1	Sun Pharmaceutical Industries Limited ₹1,172.29 Cr	Pharmaceuticals & Biotechnology	13.31%	12.37%	-0.94%
2	Lupin Limited ₹609.25 Cr	Pharmaceuticals & Biotechnology	7.25%	6.43%	-0.82%
3	Emcure Pharmaceuticals Limited ₹118.91 Cr	Pharmaceuticals & Biotechnology	1.58%	1.25%	-0.33%
4	Max Healthcare Institute Limited ₹277.00 Cr	Healthcare Services	3.15%	2.92%	-0.23%
5	Alkem Laboratories Limited ₹172.50 Cr	Pharmaceuticals & Biotechnology	2.01%	1.82%	-0.19%
6	MedPlus Health Services Limited ₹238.33 Cr	Retailing	2.69%	2.51%	-0.18%
7	Apollo Hospitals Enterprise Limited ₹488.35 Cr	Healthcare Services	5.30%	5.15%	-0.15%
8	Narayana Hrudayalaya Limited ₹157.14 Cr	Healthcare Services	1.80%	1.66%	-0.14%
9	SANOFI CONSUMER HEALTHCARE ₹88.46 Cr	Pharmaceuticals & Biotechnology	1.06%	0.93%	-0.13%
10	Abbott India Limited ₹201.96 Cr	Pharmaceuticals & Biotechnology	2.24%	2.13%	-0.11%
11	AstraZeneca Pharma India Limited ₹43.49 Cr	Pharmaceuticals & Biotechnology	0.55%	0.46%	-0.09%
12	Dr. Reddy's Laboratories Limited ₹467.50 Cr	Pharmaceuticals & Biotechnology	5.01%	4.93%	-0.08%
13	Pfizer Limited ₹149.08 Cr	Pharmaceuticals & Biotechnology	1.65%	1.57%	-0.08%
14	Fortis Healthcare Limited ₹122.08 Cr	Healthcare Services	1.37%	1.29%	-0.08%
15	Sanofi India Limited ₹93.81 Cr	Pharmaceuticals & Biotechnology	1.07%	0.99%	-0.08%
16	Thyrocare Technologies Limited ₹232.01 Cr	Healthcare Services	2.51%	2.45%	-0.06%
17	Dr. Lal Path Labs Limited ₹193.57 Cr	Healthcare Services	2.05%	2.04%	-0.01%

What Stocks Does This Fund Hold?

36 stocks — Aug 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹1,172.29 Cr	Pharmaceuticals & Biotechnology	12.37%
2	Divi's Laboratories Limited ₹663.40 Cr	Pharmaceuticals & Biotechnology	7.00%
3	Lupin Limited ₹609.25 Cr	Pharmaceuticals & Biotechnology	6.43%
4	Cipla Limited ₹577.08 Cr	Pharmaceuticals & Biotechnology	6.09%
5	Apollo Hospitals Enterprise Limited ₹488.35 Cr	Healthcare Services	5.15%
6	Dr. Reddy's Laboratories Limited ₹467.50 Cr	Pharmaceuticals & Biotechnology	4.93%
7	Mankind Pharma Limited ₹387.93 Cr	Pharmaceuticals & Biotechnology	4.09%
8	Sai Life Sciences Limited ₹373.06 Cr	Pharmaceuticals & Biotechnology	3.94%
9	Ajanta Pharma Limited ₹329.18 Cr	Pharmaceuticals & Biotechnology	3.47%
10	GlaxoSmithKline Pharmaceuticals Limited ₹314.00 Cr	Pharmaceuticals & Biotechnology	3.31%
11	Max Healthcare Institute Limited ₹277.00 Cr	Healthcare Services	2.92%
12	IPCA Laboratories Limited ₹269.52 Cr	Pharmaceuticals & Biotechnology	2.84%
13	Vijaya Diagnostic Centre Limited ₹253.82 Cr	Healthcare Services	2.68%
14	MedPlus Health Services Limited ₹238.33 Cr	Retailing	2.51%
15	Thyrocare Technologies Limited ₹232.01 Cr	Healthcare Services	2.45%
16	Gland Pharma Limited ₹231.02 Cr	Pharmaceuticals & Biotechnology	2.44%
17	Piramal Pharma Limited ₹213.06 Cr	Pharmaceuticals & Biotechnology	2.25%
18	Abbott India Limited ₹201.96 Cr	Pharmaceuticals & Biotechnology	2.13%
19	Dr. Lal Path Labs Limited ₹193.57 Cr	Healthcare Services	2.04%
20	Alkem Laboratories Limited ₹172.50 Cr	Pharmaceuticals & Biotechnology	1.82%
21	Narayana Hrudayalaya Limited ₹157.14 Cr	Healthcare Services	1.66%
22	Aurobindo Pharma Limited ₹154.98 Cr	Pharmaceuticals & Biotechnology	1.63%
23	Pfizer Limited ₹149.08 Cr	Pharmaceuticals & Biotechnology	1.57%
24	Syngene International Limited ₹140.32 Cr	Healthcare Services	1.48%
25	Suraksha Diagnostic Ltd ₹131.91 Cr	Healthcare Services	1.39%
26	Fortis Healthcare Limited ₹122.08 Cr	Healthcare Services	1.29%
27	Emcure Pharmaceuticals Limited ₹118.91 Cr	Pharmaceuticals & Biotechnology	1.25%
28	Anthem Biosciences Limited ₹113.87 Cr	Pharmaceuticals & Biotechnology	1.20%
29	Akums Drugs and Pharmaceuticals Limited ₹104.98 Cr	Pharmaceuticals & Biotechnology	1.11%
30	Biocon Limited ₹103.17 Cr	Pharmaceuticals & Biotechnology	1.09%
31	Sanofi India Limited ₹93.81 Cr	Pharmaceuticals & Biotechnology	0.99%
32	SANOFI CONSUMER HEALTHCARE ₹88.46 Cr	Pharmaceuticals & Biotechnology	0.93%
33	Indoco Remedies Ltd ₹44.65 Cr	Pharmaceuticals & Biotechnology	0.47%
34	AstraZeneca Pharma India Limited ₹43.49 Cr	Pharmaceuticals & Biotechnology	0.46%
35	Molbio Diagnostics Ltd. ₹41.31 Cr	Healthcare Equipment & Supplies	0.44%
36	Concord Biotech Limited ₹16.16 Cr	Pharmaceuticals & Biotechnology	0.17%